NCT07633704

Brief Summary

Metabolic flexibility is the ability to switch rapidly from one substrate (i.e. fuel source) to another (e.g. fats to carbohydrates) in response to ingested foods. Worse metabolic flexibility is linked to worse metabolic outcomes, but exercise is thought to be protective against nutrient excess. We will conduct a standard oral glucose tolerance test (OGTT) to assess insulin resistance and metabolic flexibility. Participants will be randomized to a 24-hour hypercaloric, high-fat diet (HFD) with and without an exercise bout. During the hypercaloric HFD, participants will eat extra calories with more calories from fat than normal, which is expected to increase insulin resistance. After each arm of the high-fat diet, we will repeat the OGTT. During each OGTT, expired gases will be analyzed noninvasively to determine metablic flexibility. Insulin resistance will be determined with blood drawn during each OGTT. By comparing metabolic flexiblity and insulin resistance before and after the normal diet and after the high-fat diet intervention, a better understanding of how insulin resistance affects metabolism and how exercise can be protective will be developed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2026

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 11, 2026

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 8, 2026

Completed
Last Updated

June 8, 2026

Status Verified

April 1, 2026

Enrollment Period

1.2 years

First QC Date

May 11, 2026

Last Update Submit

June 4, 2026

Conditions

Keywords

MetabolismExerciseSubstrate OxidationOverfeedingHigh Fat Diet

Outcome Measures

Primary Outcomes (1)

  • Insulin Sensitivity via Oral Glucose Insulin Sensitivity Index

    Oral Glucose Insulin Sensitivity

    Immediately following high fat diet intervention

Secondary Outcomes (2)

  • Metabolic Flexibility (Respiratory Exchange Ratio) via Indirect Calorimetry

    Immediately following high fat diet intervention

  • Carotid Femoral Pulse Wave velocity

    Immediately following high fat diet intervention

Study Arms (2)

High Fat Overfeeding

EXPERIMENTAL

Resting metabolic rate will be used estimate total caloric need. We will use this estimate to create a daily target calorie intake and target fat intake for the High-Fat Diets (HFD) in the study. During the high-fat diet, subjects will eat 80% more calories than necessary with at least 65% of the calories coming from fat for one day.

Behavioral: High Fat Overfeeding

High Fat Overfeeding + Exercise

EXPERIMENTAL

On the day of High Fat Overfeeding (See High Fat Overfeeding arm description), subjects will complete a single bout of exercise. The duration of exercise will be individualized to \~25% of daily energy needs.The intensity of exercise will be individualized to be at a low intensity in the moderate domain. Extra foods will be provided to match energy balance across the high-fat overfeeding days

Behavioral: High Fat Overfeeding + Exercise

Interventions

Caloric intake 180% of daily caloric need with 65% from fat

High Fat Overfeeding

Caloric intake 180% of daily caloric need with 65% from fat with acute moderate exercise (energy expenditure \~25% of daily caloric need).

High Fat Overfeeding + Exercise

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Males or females between the ages of 20 and 40 years
  • A body mass index (BMI) of 20.0 - 29.9 kg/m2.
  • Low risk for risk of injury or health complications as determined by physical activity readiness questionnaire (PARQ).

You may not qualify if:

  • Are currently taking any antioxidant supplementation (daily multivitamin not included), prescribed non-steroidal anti-inflammatory drugs (NSAIDS), antibiotics, steroids, or probiotics.
  • Are currently taking any medications for management of cholesterol, diabetes, or body weight/obesity, or are undergoing hormone therapy.
  • Are unwilling or unable to comply with study procedures, at the discretion of the investigators.
  • Are unwilling to have biospecimens (blood and urine) collected and stored (only blood) for future research.
  • Pregnant women - A urine pregnancy test will be conducted prior to any testing procedures.
  • A history of disordered eating, including anorexia nervosa, bulimia nervosa, binge eating disorder, or avoidant restrictive food intake disorder or deemed high-risk for disordered eating via questionnaire.
  • A history of gastrointestinal diseases, such as galactosemia, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), Celiac disease, Crohn's disease, or lactose intolerance.
  • Individuals with known allergies to wheat or gluten, milk, soy, tree nuts (e.g., almonds, walnuts, pecans), or peanuts.
  • Deemed high risk for food insecurity via the Hunger Vital Sign screener.
  • Have followed a ketogenic diet within the last three months or have been told to avoid a high-fat diet by a medical provider for risk of cardiovascular disease.
  • Cardiorespiratory fitness (VO2max) below the 30th percentile for age and sex (measured at initial screening visit)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Milken Institute School of Public Health

Washington D.C., District of Columbia, 20052, United States

Location

MeSH Terms

Conditions

Insulin ResistanceMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Matthew Barberio

    George Washington University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 11, 2026

First Posted

June 8, 2026

Study Start

February 10, 2025

Primary Completion

April 7, 2026

Study Completion

April 9, 2026

Last Updated

June 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Individual data will be annonymized by study ID number and removed of any identifying information. Data will be shared upon reasonable request.

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
Upon publication, data will be shared upon reasonable request to the corresponding author.

Locations